Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio
]pyrimidine scaffold to cytotoxic and pro-apoptotic activity. When combined with mechanistic and computational evidence, the clear SAR trends based on halogen type and position provide strong support for optimizing the next generation of anticancer agents, especially in the context of therapeutic resistance in breast cancer.
Authors
- Bagher A. Larijani (ORCID: https://orcid.org/0000-0001-5386-7597)
- Cambyz Irajie (ORCID: https://orcid.org/0000-0001-8438-2146)
- Aida Iraji (ORCID: https://orcid.org/0000-0002-8442-2205)
- Vahid Haghpanah (ORCID: https://orcid.org/0000-0001-8337-0602)
- Mohammad Hosein Sayahi (ORCID: https://orcid.org/0000-0001-9383-6269)
- Mohammad Reza Mahdavi (ORCID: https://orcid.org/0000-0002-8007-2543)
- Mina Saeedi (ORCID: https://orcid.org/0000-0002-9046-8058)
- Ashkan Khademi
Institutions
- Shiraz University of Medical Sciences (IR)
- Shahid Chamran University of Ahvaz (IR)
- Endocrinology and Metabolism Clinical Sciences Institute (IR)
- Metabolomics and Genomics Research Center (IR)
- Endocrinology and Metabolism Molecular-Cellular Sciences Institute (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- RSC Advances
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1039/d6ra06870g
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shiraz University of Medical Sciences